GALAMIDI EINAT enters ENLIVEX LTD. with 156.30K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001213900-26-029566
Officer· Chief Medical Officer
Since Mar 2026
156.30K
Baseline shares
100% direct
156.30K
Direct ownership
1 position
35K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares, par value NIS 0.40 per share
DirectShares owned156.30K
Total
156.30K direct156.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares, par value NIS 0.40 per share | 156.30K | Direct |
| Total | 156.30K | 156.30K direct |
Derivative Holdings2
Employee Stock Option (right to buy)
DirectUnderlying security
Ordinary Shares, par value NIS 0.40 per share
Underlying shares
10K
Shares owned
N/A
Exercise price
3.21
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Ordinary Shares, par value NIS 0.40 per share
Underlying shares
25K
Shares owned
N/A
Exercise price
5.34
Expiration
—
Exercise window
—
Total
Underlying
35K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Ordinary Shares, par value NIS 0.40 per share | 3.21 | — | — | 10K | N/A |
| Employee Stock Option (right to buy) Direct | Ordinary Shares, par value NIS 0.40 per share | 5.34 | — | — | 25K | N/A |
| Total | 35K | 0.00 | ||||